首页|伏诺拉生联合阿莫西林+克拉霉素治疗幽门螺杆菌感染的消化性溃疡的临床疗效评价

伏诺拉生联合阿莫西林+克拉霉素治疗幽门螺杆菌感染的消化性溃疡的临床疗效评价

扫码查看
目的 分析幽门螺杆菌(Helicobacter Pylori,Hp)感染性消化性溃疡采取不同药物方案治疗后的效果,验证伏诺拉生联合阿莫西林+克拉霉素治疗临床优势.方法 单纯随机选取建湖县人民医院消化内科于2023年1-12月期间收治的80例Hp感染性消化性溃疡患者作为研究对象,以随机数表法分为两组,各40例.对照组采用三联疗法,观察组采用伏诺拉生联合阿莫西林+克拉霉素.比较两组治疗效果、Hp根治率、不良反应、生活质量和炎症指标.结果 治疗后,观察组治疗总有效率(95.00%)高于对照组(75.00%),差异有统计学意义(x2=5.275,P=0.012).两组不良反应发生情况比较,差异无统计学意义(P>0.05).观察组Hp根治率和生活质量量表各维度评分均优于对照组,差异有统计学意义(P均<0.05).治疗后,两组患者的肿瘤坏死因子-α和白细胞介素-8水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P均<0.05).结论 伏诺拉生联合阿莫西林+克拉霉素治疗Hp消化性溃疡的临床疗效较好、安全性较高,可有效根治Hp,改善患者的炎性因子水平,提升患者的生活质量.
Clinical Efficacy Evaluation of Venolazan Combined with Amoxicillin and Clarithromycin in the Treatment of Peptic Ulcer Infected with Helico-bacter Pylori
Objective To analyze the effects of different drug regimens in the treatment of peptic ulcer infected with helicobacter pylori(Hp),and to verify the clinical advantages of Venolazan combined with amoxicillin and clarithromy-cin.Methods A total of eighty patients with Hp infectious peptic ulcer admitted to the gastroenterology department of Jianhu County People's Hospital from January to December 2023 were randomly selected as the study objects and di-vided into two groups with forty cases each by random number table method.The control group was treated with triple therapy,the observation group was treated with Venolazan combined with amoxicillin+clarithromycin.The therapeu-tic effect,Hp radical rate,adverse reactions,quality of life and inflammation indexes were compared between the two groups.Results After treatment,the total effective rate of treatment observation group(95.00%)was higher than that of control group(75.00%),and the difference was statistically significant(x2=5.275,P=0.012).There was no significant difference in the occurrence of adverse reactions between the two groups(P>0.05).Hp radical treatment rate and qual-ity of life scale scores in the observation group were better than those in the control group,the differences were statisti-cally significant(all P<0.05).After treatment,the levels of tumor necrosis factor-α and interleukin-8 in both groups were lower than before treatment,and the observation group was lower than the control group and the differences were statistically significant(all P<0.05).Conclusion Venolazan combined with amoxicillin+clarithromycin has good clini-cal efficacy and high safety in the treatment of Hp peptic ulcer,which can effectively cure Hp,improve the level of in-flammatory factors in patients,and improve the quality of life of patients.

Helicobacter pyloriVenolazanPeptic ulcerTherapeutic effectAdverse reactionsQuality of lifeInflammatory index

沈阳、薛成俊、尤国莉

展开 >

建湖县人民医院消化内科,江苏盐城 224700

幽门螺杆菌 伏诺拉生 消化性溃疡 治疗效果 不良反应 生活质量 炎症指标

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(15)